Articles

BioSante Pharmaceuticals, inhaled insulin studies show a 60% bioavailability of its inhaled insulin delivery system compared to only 10-15% absorption of Exubera inhaled insulin.

New study suggests that people with diabetes could be up to three times more likely to get bowel cancer.

The news that Pfizer had been granted an approval recommendation in the US for its inhaled formulation of insulin, Exubera, has been swiftly followed by the news that a rival formulation in development at Eli Lilly has cleared a Phase II clinical trial.

Each 1-percentage-point increase in HbA1c level was associated with a 14 percent increase in heart disease risk.

The new target, a molecule called hVps34, is activated by amino acids (nutrients) entering the cell. This molecule triggers the activation of an enzyme, S6 Kinase 1 (S6K1), whose function is linked to obesity and insulin resistance.

For patients who do not respond adequately to simvastatin or who have adverse reactions to this statin, switching to atorvastatin is safe and effective.

Diabetes goes from 7th leading cause of death to 5th leading cause of death.

Aspirin cessation in adults at high risk of cerebrovascular disease increases the risk of stroke and TIA.

Human fat cells produce a protein that is linked to both inflammation and an increased risk of heart disease and stroke. Researchers found that aspirin and statin drugs, reduce production of CRP from fat cells

Individuals with impaired fasting glucose levels are at increased risk of death after coronary artery bypass grafting.